Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Imaging, Diagnosis, Prognosis

HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients

Pia Wülfing, Julia Borchard, Horst Buerger, Stefan Heidl, Kurt S. Zänker, Ludwig Kiesel and Burkhard Brandt
Pia Wülfing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Borchard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Horst Buerger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Heidl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt S. Zänker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludwig Kiesel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Burkhard Brandt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-05-2087 Published March 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2006 to February 2021

AbstractFull-text HTMLPDF
Total654482934305

Cited By

Article Information

Volume 12, Issue 6, pp. 1715-1720

DOI 
https://doi.org/10.1158/1078-0432.CCR-05-2087
PubMed 
16551854

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted January 3, 2006
  • Received September 23, 2005
  • Revision received November 30, 2005
  • Published first March 21, 2006.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Pia Wülfing1,
  2. Julia Borchard1,
  3. Horst Buerger2,
  4. Stefan Heidl3,
  5. Kurt S. Zänker4,
  6. Ludwig Kiesel1 and
  7. Burkhard Brandt5
  1. Authors' Affiliations:1Department of Obstetrics and Gynecology, 2Gerhard-Domagk Institute of Pathology, and 3Institute of Clinical Chemistry and Laboratory Medicine, University of Münster, Münster, Germany; 4Institute of Immunology, University of Witten/Herdecke, Witten, Germany; and 5Institute of Tumor Biology, University Medical Centre, Hamburg, Germany
  1. Requests for reprints:
    Pia Wülfing, Department of Obstetrics and Gynecology, University of Münster, Albert-Schweitzer-Str. 33, 48149 Münster, Germany. Phone: 49-251-834-8202; Fax: 49-251-834-8267; E-mail: wuelfip{at}uni-muenster.de.
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 12 (6)
March 2006
Volume 12, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients
Pia Wülfing, Julia Borchard, Horst Buerger, Stefan Heidl, Kurt S. Zänker, Ludwig Kiesel and Burkhard Brandt
Clin Cancer Res March 15 2006 (12) (6) 1715-1720; DOI: 10.1158/1078-0432.CCR-05-2087

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients
Pia Wülfing, Julia Borchard, Horst Buerger, Stefan Heidl, Kurt S. Zänker, Ludwig Kiesel and Burkhard Brandt
Clin Cancer Res March 15 2006 (12) (6) 1715-1720; DOI: 10.1158/1078-0432.CCR-05-2087
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • 18FDG PET-MRI of Breast Tumors: Feasibility
  • TP53 in Breast Cancer
  • FDOPA PET Survival Predictions for Glioma
Show more Imaging, Diagnosis, Prognosis
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement